Title: Progressive Decline in Hippocampal CA1 Volume in Individuals at Ultra-High-Risk for Psychosis Who Do Not Remit: Findings from the Longitudinal Youth at Risk Study
year: 2017
Journal: Neuropsychopharmacology
Volume: 42
Issue: 6
Pages: 1361-1370
date: May
ISSN: 1740-634X (Electronic);0893-133X (Linking)
Legal note: PMC5437892
Article Number: 28079061
Keywords: Adolescent;Adult;CA1 Region, Hippocampal/diagnostic imaging/*pathology;*Disease Progression;Female;Humans;Longitudinal Studies;Magnetic Resonance Imaging;Male;*Prodromal Symptoms;Psychotic Disorders/diagnostic imaging/*pathology/*physiopathology;Risk;Severity of Illness Index;Young Adult
Abstract: Most individuals identified as ultra-high-risk (UHR) for psychosis do not develop frank psychosis. They continue to exhibit subthreshold symptoms, or go on to fully remit. Prior work has shown that the volume of CA1, a subfield of the hippocampus, is selectively reduced in the early stages of schizophrenia. Here we aimed to determine whether patterns of volume change of CA1 are different in UHR individuals who do or do not achieve symptomatic remission. Structural MRI scans were acquired at baseline and at 1-2 follow-up time points (at 12-month intervals) from 147 UHR and healthy control subjects. An automated method (based on an ex vivo atlas of ultra-high-resolution hippocampal tissue) was used to delineate the hippocampal subfields. Over time, a greater decline in bilateral CA1 subfield volumes was found in the subgroup of UHR subjects whose subthreshold symptoms persisted (n=40) and also those who developed clinical psychosis (n=12), compared with UHR subjects who remitted (n=41) and healthy controls (n=54). No baseline differences in volumes of the overall hippocampus or its subfields were found among the groups. Moreover, the rate of volume decline of CA1, but not of other hippocampal subfields, in the non-remitters was associated with increasing symptom severity over time. Thus, these findings indicate that there is deterioration of CA1 volume in persistently symptomatic UHR individuals in proportion to symptomatic progression.
Notes: Ho, New Fei;Holt, Daphne J;Cheung, Mike;Iglesias, Juan Eugenio;Goh, Alex;Wang, Mingyuan;Lim, Joseph Kw;de Souza, Joshua;Poh, Joann S;See, Yuen Mei;Adcock, Alison R;Wood, Stephen J;Chee, Michael Wl;Lee, Jimmy;Zhou, Juan;eng;R01 MH095904/MH/NIMH NIH HHS/;England;2017/01/13 06:00;Neuropsychopharmacology. 2017 May;42(6):1361-1370. doi: 10.1038/npp.2017.5. Epub 2017 Jan 12.
URL: https://www.ncbi.nlm.nih.gov/pubmed/28079061;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5437892/pdf/npp20175a.pdf
URI: https://open-access.imh.com.sg/handle/123456789/5121
Authors Address: Institute of Mental Health, Singapore, Singapore.;Neuroscience and Behavioral Disorders Program, Center for Cognitive Neuroscience, Duke-National University of Singapore Graduate Medical School, Singapore, Singapore.;Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.;Department of Psychology, National University of Singapore, Singapore, Singapore.;University College London, London, UK.;Center for Cognitive Neuroscience, Duke University, Durham, NC, USA.;School of Psychology, University of Birmingham, Birmingham, UK.
Appears in Collections:2017

Files in This Item:
File Description SizeFormat 
Ho-2017-Progressive Decline in Hippocampal CA1.pdf321.06 kBAdobe PDFThumbnail

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.